Exploring Out-of-Pocket Costs and Health-Related Quality of Life among Patients with Cancer and Diabetes in Malaysia
Main Article Content
Abstract
Background: Out-of-pocket costs for chronic illnesses have become significant barriers to continuing treatment, given the already substantial cost of the diseases. This study aims to estimate out-of-pocket costs and determine the health-related quality of life of patients with cancer and diabetes.
Methods: A purposive cross-sectional study (January 2021–January 2022) was conducted to assess health-related quality of life and out-of-pocket costs among Malaysian adults with cancer or diabetes. Using the validated EQ-5D-5L and a three-section questionnaire, 571 participants from three hospitals and online surveys provided data on five cost categories expressed in 2021 MYR and USD.
Results: Significant differences were observed across all cost categories between patients with cancer and diabetes. Diagnostic imaging had a larger effect size (P < 0.0001, r = 0.467). Annual outpatient and hospitalisation costs among patients with cancer were found to be 42 and 11 times higher than for patients with diabetes, respectively. Overall, the out-of-pocket expenditure per year for patients with cancer was MYR 88,346.12 and MYR 9,010.60 for patients with diabetes. Additionally, patients with cancer rated their health-related quality of life using the EQ-VAS score lower than patients with diabetes (EQ-VAS = 63.7, SD = 19.2 and EQ-VAS = 71.6, SD = 18.7).
Conclusion: Cancer and diabetes impose significant financial and quality of life burdens on patients in Malaysia. This study highlights gaps in insurance coverage and public assistance, calling for more comprehensive support for medical and nonmedical expenses and psychological support for patients. The analysis, which focuses on annual costs, may underestimate the long-term financial impact, especially for patients with cancer. Future research should examine household spending and the ability to pay for treatment costs to better understand the full economic burden of these chronic diseases.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Tur-Sinai A, Urban D, Azoulay D, Bar Sela G, Bentur N. Understanding out-of-pocket spending and financial hardship among patients who succumb to cancer and their caregivers. Israel J Health Policy Res. 2022;11(1):1. https://doi.org/10.1186/s13584-021-00511-8
Azzani M, Dahlui M, Wan Ishak WZW, Roslani AC, Su TT. Provider costs of treating colorectal cancer in government hospital of Malaysia. Malays J Med Sci. 2019;26(1):73–86. https://doi.org/10.21315/mjms2019.26.1.7
Hassan NZAM, Kunusagaran MSJMNS, Zaimi NA, Aminuddin F, Rahim FIA, Jawahir S, et al. The inequalities and determinants of households’ distress financing on out-of-pocket health expenditure in Malaysia. BMC Public Health. 2022;22:449. https://doi.org/10.1186/s12889-022-12834-5
Ministry of Health Malaysia. National Strategic Plan for Cancer Control Programme 2016–2020. Putrajaya: Non-Communicable Disease Section, Disease Control Division, Ministry of Health Malaysia; 2017.
Ministry of Health Malaysia. National Strategic Plan for Cancer Control Programme 2021–2025. Putrajaya: Non-Communicable Disease Section, Disease Control Division, Ministry of Health Malaysia; 2021.
Ministry of Health Malaysia. National Strategic Plan for Non-Communicable Disease (NSP-NCD) 2016–2025. Putrajaya: Non-Communicable Disease Section, Disease Control Division, Ministry of Health Malaysia; 2016.
World Health Organization, World Bank. Financing for NCDs and mental health: Where will the money come from? International Dialogue on Sustainable Financing for Noncommunicable Disease and Mental Health. Washington (DC): World Bank; 2025. Available at: http://hdl.handle.net/10986/42871
Matebie GY, Mebratie AD, Demeke T, Afework B, Kantelhardt EJ, Addissie A. Catastrophic health expenditure and associated factors among hospitalized cancer patients in Addis Ababa, Ethiopia. Risk Manag Healthc Policy. 2024;17:537–548. https://doi.org/10.2147/RMHP.S434075
Ganasegeran K, Hor CP, Jamil MFA, Loh HC, Noor JM, Hamid NA, et al. A systematic review of the economic burden of type 2 diabetes in Malaysia. Int J Environ Res Public Health. 2020;17(16):5723. https://doi.org/10.3390/ijerph17165723
Schlueter M, Chan K, Lasry R, Price M. The cost of cancer – A comparative analysis of the direct medical costs of cancer and other major chronic diseases in Europe. PLoS One. 2020;15(11):e0241354. https://doi.org/10.1371/journal.pone.0241354
Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–539. https://doi.org/10.1038/s41574-022-00690-7
Akhtar S, Nasir JA, Ali A, Asghar M, Majeed R, Sarwar A. Prevalence of type 2 diabetes and prediabetes in Malaysia: a systematic review and meta-analysis. PLoS One. 2022;17(1):e0263139. https://doi.org/10.1371/journal.pone.0263139
Lazam NM, Shair SN, Asmuni NH, Jamaludin A, Yusri AA. Forecasting the incidence rates of top three cancers in Malaysia. AIP Conf Proc. 2023;2500(1):020052. https://doi.org/10.1063/5.0110929
Cochran WG. Sampling Techniques. 2nd ed. New York: John Wiley and Sons, Inc; 1977.
Naing NN. Determination of sample size. Malays J Med Sci. 2003;10(2):84–86.
Ali MD, Al Hatef EAJ. Types of sampling and sample size determination in health and social science research. J Young Pharm. 2024;16(2):204–215. https://doi.org/10.5530/jyp.2024.16.27
EuroQol Research Foundation. EQ-5D-5L user guide. Version 3.0 2019 [Internet]. Rotterdam: EuroQol Research Foundation; 2019 [Retrieved 2025 Jul 29]. Available at: https://euroqol.org/publications/user-guides
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. https://doi.org/10.1016/0168-8510(90)90421-9
Faraway JJ. Generalized linear models. In: Peterson P, Baker E, McGaw B, editors. International encyclopedia of education. 3rd ed. Oxford: Elsevier; 2010. pp. 537–546. https://doi.org/10.1016/B978-0-08-044894-7.01331-2
McCullagh P. Introduction to Nelder and Wedderburn (1972) generalized linear models. In: Kotz S, Johnson NL, editors. Breakthroughs in statistics. New York: Springer; 1992. pp. 543–546. https://doi.org/10.1007/978-1-4612-4380-9_38
Nelder JA, Wedderburn RWM. Generalized linear models. J R Stat Soc Ser A Gen. 2018;135(3):370–384. https://doi.org/10.2307/2344614
Wadasadawala T, Mohanty SK, Sen S, Khan PK, Pimple S, Mane JV, et al. Health-related quality of life (HRQoL) using EQ-5D-5L: value set derived for Indian breast cancer cohort. Asian Pac J Cancer Prev. 2023;24(4):1199–1207. https://doi.org/10.31557/APJCP.2023.24.4.1199
Department of Statistics Malaysia. Key findings population and housing census of Malaysia 2020. Putrajaya, Malaysia: Department of Statistics Malaysia; 2022.
Wan Puteh SE, Razali H, Ismail A, Zulkifli M. Health status based on EQ-5D-5L for the cancer patient population in Malaysia. Sci Rep. 2024;14(1):8152. https://doi.org/10.1038/s41598-024-58844-8
Wan Puteh SE, Siwar C, Zaidi MAS, Abdul Kadir H. Health-related quality of life (HRQoL) among low socioeconomic population in Malaysia. BMC Public Health. 2019;19(Suppl 4):551. https://doi.org/10.1186/s12889-019-6853-7
Liu H, Zhu X, Yu J, He P, Shen B, Tang X, et al. The quality of life of patients with colorectal cancer and a stoma in China: a quantitative cross-sectional study. Adv Skin Wound Care. 2021;34(6):302–307. https://doi.org/10.1097/01.ASW.0000744348.32773.b9
Hung HW, Liu CY, Chen HF, Chang CC, Chen SC. Impact of chemotherapy-induced peripheral neuropathy on quality of life in patients with advanced lung cancer receiving platinum-based chemotherapy. Int J Environ Res Public Health. 2021;18(11):5677. https://doi.org/10.3390/ijerph18115677
Patterson JM, Lu L, Watson LJ, Harding S, Ness AR, Thomas S, et al. Associations between markers of social functioning and depression and quality of life in survivors of head and neck cancer: Findings from the Head and Neck Cancer 5000 study. Psychooncology. 2022;31(3):478–485. https://doi.org/10.1002/pon.5830
Hulbert-Williams NJ, Leslie M, Hulbert-Williams L, Smith E, Howells L, Pinato DJ. Evaluating the impact of COVID-19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network. Eur J Cancer Care. 2021;30(5):e13442. https://doi.org/10.1111/ecc.13442
Lewandowska A, Rudzki G, Lewandowski T, Próchnicki M, Rudzki S, Laskowska B, et al. Quality of life of cancer patients treated with chemotherapy. Int J Environ Res Public Health. 2020;17(19):6938. https://doi.org/10.3390/ijerph17196938
Konieczny M, Cipora E, Sygit K, Fal A. Quality of life of women with breast cancer and socio-demographic factors. Asian Pac J Cancer Prev. 2020;21(1):185–193. https://doi.org/10.31557/APJCP.2020.21.1.185
Halpern MT, Liu B, Lowy DR, Gupta S, Croswell JM, Doria-Rose VP. The annual cost of cancer screening in the United States. Ann Intern Med. 2024;177(9):1170–1178. https://doi.org/10.7326/M24-0375
Greco L, Luta G, Wilcox R. On testing the equality between interquartile ranges. Comput Stat. 2024;39(5):2873–2898. https://doi.org/10.1007/s00180-023-01415-8
Liew CH, Shabaruddin FH, Dahlui M. The burden of out-of-pocket expenditure related to gynaecological cancer in Malaysia. Healthcare. 2022;10(10):2099. https://doi.org/10.3390/healthcare10102099
Raman S, Shafie AA, Abraham MT, Shim CK, Maling TH, Rajendran S, et al. Household catastrophic health expenditure from oral potentially malignant disorders and oral cancer in public healthcare of Malaysia. Asian Pac J Cancer Prev. 2022;23(5):1611–1618. https://doi.org/10.31557/APJCP.2022.23.5.1611
Merollini KMD, Collins LG, Jones AT, Aitken JF, Kimlin MG. Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (COS-Q). Cancer Med. 2024;13(17):e70201. https://doi.org/10.1002/cam4.70201
Abrams HR, Durbin S, Huang CX, Johnson SF, Nayak RK, Zahner GJ, et al. Financial toxicity in cancer care: Origins, impact, and solutions. Transl Behav Med. 2021;11(11):2043–2054. https://doi.org/10.1093/tbm/ibab091
Aminuddin F, Raman S, Bahari MS, Zaimi NA, Mohd Nor Sham Kunusagaran MSJ, Zainuddin NA, et al. Cancer impact on lower-income patients in Malaysian public healthcare: An exploration of out-of-pocket expenses, productivity loss, and financial coping strategies. PLoS One. 2024;19(10):e0311815. https://doi.org/10.1371/journal.pone.0311815